Physician profile
Gavin Sigle
NPI 1497917561
$15,173.82
in general payments reported to CMS, 2019-2025
25 companies · $2,627 in 2025
The $2,627 reported for 2025 was more than what 83% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $293 · 2021: $893 · 2022: $1,634 · 2023: $5,271 · 2024: $3,497 · 2025: $2,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,395 · Travel and Lodging: $2,300 · Education: $2,000 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,394.65 |
| Travel and Lodging | $2,300.30 |
| Education | $2,000.00 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,322.09 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Thd America, INC. | $3,252.02 | 2019-2025 | |
| Integra Lifesciences Corporation | $1,501.00 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $1,100.61 | 2021-2024 | Signia, Eea, Interstim |
| Aroa Biosurgery Incorporated | $1,017.95 | 2023-2025 | |
| Conmed Corporation | $447.43 | 2021-2025 | Airseal, Conmed Biliary, Conmed Dilation |
| Stryker Corporation | $361.18 | 2022 | |
| Axonics, INC. | $313.53 | 2021-2023 | Axonics |
| Davol INC. | $172.33 | 2023 | Phasix Mesh |
| Organogenesis INC. | $138.14 | 2023 | Puraply |
| Acell, INC. | $113.03 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $63.39 | 2023 | Keytruda, Lynparza |
| Tela Bio, INC. | $57.64 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $51.96 | 2023 | Floseal |
| Surgenex LLC | $42.46 | 2025 | Renograft, Pellograft, Surmatrix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $34.04 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.76 | 2023 | Seglentis |
| Innovation Technologies INC | $24.27 | 2021 | |
| Myriad Genetic Laboratories, INC. | $24.17 | 2024 | Myrisk |
| Qol Medical, LLC | $22.84 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $20.85 | 2024 | |
| Kerecis Limited | $20.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Molnlycke Health Care US, LLC | $15.08 | 2024 | Mepilex Border Sacrum, Mepilex Border Flex, Mepilex Border Post-Op Ag |
| Livanova USA, INC. | $13.40 | 2019 | |
| Smith+Nephew, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Sigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.